ORTEXORTEX News
Tracking FTRE? Get live short interest, options flow, and signals on ORTEX.Sign up free →
FT
Earnings PreviewFTRE

Fortrea Short Interest Climbs to a Year-High Ahead of Sunday's Print

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 23 Oct 2026, 04:01

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Short sellers have built their largest position in FTRE in at least a year, with short interest now at 14.6% of the free float, up 10.5% over the past month and 3.6% over the past week alone. The absolute share count reached 13.5 million on October 21, the highest reading in the 30-day history visible in the data. Despite that accumulation, borrow conditions remain unusually relaxed: availability is running at 1,108%, meaning there are roughly eleven shares available to lend for every one already borrowed, and the cost to borrow has eased nearly 20% over the past week to just 0.42%. Options positioning sits at the other end of the sentiment dial, with a put/call ratio of 0.04, well below its 20-day average and near the lower end of the past year's range, suggesting options traders are not hedging aggressively despite the growing short position.

The stock itself has gained 19.5% over the past month and 5.2% over the past week, broadly in line with its closest peers. IQV rose 5.6% over the same week, ICLR gained 9.6%, and CRL put on 14.2%, so FTRE's recent move reflects a sector-wide lift rather than company-specific news. The divergence between rising short interest and a rising share price points to shorts building into the rally rather than exiting, a tension that the October 26 result will need to resolve.

Analyst opinion has shifted materially in the weeks before the print. Deutsche Bank upgraded the stock to Buy and lifted its target from $20 to $25 on October 15. Barclays moved to Overweight with a $23 target on October 6, having previously been at Equal-Weight. UBS initiated at Neutral with a $22 target in late September, then raised that to $24 on October 20. The consensus mean price target is $21.71, modestly below the current price of $23.92, which reflects the gap between pre-rally targets and a stock that has moved faster than the Street has revised. The analyst recommendation differential ranks in the 97th percentile across the ORTEX universe, a sign the Street's positive tilt is unusually pronounced.

One ownership detail stands out. Starboard Value, which filed a Schedule 13D activist position earlier in 2025, has since reduced its disclosed stake to 3.0% from a prior 5.4%, below the threshold at which further filing is required. As a result, Starboard's current position is unknown; the 13D/G register reflects what was last disclosed, and a holder can fall below 5% without filing again. BlackRock remains the largest reported holder at 16.6% of shares. The CEO, Anshul Thakral, sold roughly $3.9 million of stock across four open-market transactions in early August at prices between $18.06 and $19.28, well below where the shares trade now. No insider buying has been recorded in the period covered.

Past prints have been punishing: the two prior earnings events both produced day-one declines exceeding 6%, with the most recent August result dropping 6.2% on the day. The October 26 report will test whether the improved analyst backdrop and a 19% one-month rally have reset expectations to a level the company's underlying numbers can support.

Stocks in this article

See the live data behind this article on ORTEX.

Open FTRE on ORTEX →

How this article was generated

Generated
23 Oct 2026, 04:23
Data as of
23 Oct 2026, 04:01
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.